Company: CCHH
Filing Date: 2025-06-26
Form Type: DRS
Source: 0001213900-25-058036
Chunk: 12

Company: CCH Holdings Ltd
Filing Date: 2025-06-26
Form: DRS
Chunk 12
---
able or exercisable for our ordinary shares, for a period of [six months] from the date of closing of this offering.] See “Shares Eligible for Future Sale” and “Underwriting.”           |
| Listing                                                              |     | We intend to apply to have our ordinary shares listed on the Nasdaq Capital Market under the symbol “[    ].”                                                                                                                                                                                                                                                                                                                                                                                                            |
| Payment and Settlement                                               |     | The underwriters expect to deliver against payment on [    ], 2025, through the facilities of The Depository Trust Company, or DTC.                                                                                                                                                                                                                                                                                                                                                                                      |
| Risk Factors                                                         |     | See “Risk Factors” and other information included in this prospectus for a discussion of risks you should carefully consider before investing in our ordinary shares.                                                                                                                                                                                                                                                                                                                                                    |
| Capital Structure and Voting Rights                                  |     | Our authorized share capital is US$50,000 divided into 5,000,000,000 shares of a par value of US$0.00001 per share.                                                                                                                                                                                                                                                                                                                                                                                                      
 Holders of ordinary shares are entitled to one vote per one ordinary share. See “Description of Share Capital.”                                                                                                                                                                                                                                                                                                                                                                                                          |

7

SUMMARY CONSOLIDATED FINANCIAL DATA The following summary consolidated statements of operations data and summary consolidated cash flow data for the years ended December 31, 2023 and 2024, and summary consolidated balance sheet data as of December 31, 2023 and 2024 have been derived from our audited consolidated financial statements included elsewhere in this prospectus. Our consolidated financial statements are prepared and presented in accordance with accounting principles generally accepted in the United States of America, or U.S. GAAP. Our historical results are not necessarily indicative of results expected for future periods. You should read this Summary Consolidated Financial Data section together with our consolidated financial statements and the related notes and “ Management’s Discussion and Analysis of Financial Condition and Results of Operations” included elsewhere in this prospectus. The following table presents our summary consolidated statements of operations data for the periods indicated.

|                                     |     | For the Years Ended 
 December 31,        |       2023 |   |     |   |       2024 |   |
|:------------------------------------|:----|:--------------------|-----------:|:--|:----|:--|-----------:|:--|
| Revenues                            |     | $                   |  9,775,038 |   |     | $ |  8,915,344 |   |
| –